Figure S4 from KDM4 Inhibition Targets Breast Cancer Stem–like Cells

Authors :: Roland Schüle
Jochen Maurer
Toufike Kanouni
Jeffrey A. Stafford
Michael B. Wallace
Jiangchun Xu
Elmar Stickeler
Melanie Boerries
Marie Follo
Amelie Proske
Peter Bronsert
Nicola Iovino
Fides Zenk
Anita Allen
Dominica Willmann
Sylvia Urban
Bogdan-Tiberius Preca
Juliane Strietz
Stella S. Stepputtis
Eric Metzger
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Additional evidence showing control of EGFR expression by QC6352 is presented here. The specific EGFR inhibitor erlotinib diminishes proliferation and sphere formation in BCSC1 and BCSC2.

Tools